Ajinomoto OmniChem, provider of small molecule API, contract development and manufacturing services, has announced the completion of a commercial scale manufacturing campaign that involves adapting a traditional multi-step batch process into a continuous flow chemistry platform.
Continuous flow manufacturing can reduce processing time, increase reaction selectivity, and better product quality. The mobile installation of the continuous flow platform was designed and implemented in OmniChem's pilot plan facility based in Wetteren, Belgium.
"We have been very eager to implement our continuous flow design and our teams have gained significant knowledge around this platform which will facilitate rapid changeovers and modifications for future client programs,” Dr. Eric De Vos, Business Unit and R&D Director of Pharmaceutical Fine Chemicals said.
The continuous flow capability enables R&D and scale up to 100kg commercial levels and its modular construction allows for adaptation to other manufacturing processes.
OmniChem received multi-year grant awards from the Belgian government to expand its processing windows and develop reactors for rapid and selective chemical conversions in collaboration with technology providers.